| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |